Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Neuren Pharmaceuticals (NEU AU)
Watchlist
38
Analysis
Health Care
•
Australia
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company. The Company researches neurological and metabolic disorders.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Ramelius Resources
•
17 Aug 2023 06:04
S&P/ASX Index Rebalance Preview: Potential Adds Have Outperformed
We forecast 26 changes across the ASX50, ASX100, ASX 200 and ASX300 indices at the September rebalance. There is big flow and impact on a lot of...
Brian Freitas
Follow
534 Views
Share
bullish
•
Wistron Corp
•
23 Jul 2023 08:41
Index Rebalance & ETF Flow Recap: ASX, SK Telecom, Yuanta ETFs
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
473 Views
Share
bullish
•
Data#3 Ltd
•
19 Jul 2023 05:09
S&P/ASX200 Ad Hoc Index Rebalance & Update to Potential Changes in September
Ventia replaces Blackmores in the ASX200 at the close on 21 July. That also leads to changes to potential adds/deletes in September. WBT and DTL...
Brian Freitas
Follow
553 Views
Share
bullish
•
Ventia
•
18 Jul 2023 23:04
Ventia Services (VNT) Selected to Join ASX 200 - Not A Surprise
Ventia (VNT AU) was chosen to join the S&P ASX 200 on Friday's close, replacing Blackmores. It was not that much of a surprise. There have been...
Travis Lundy
Follow
502 Views
Share
bullish
•
Neuren Pharmaceuticals
•
16 Jul 2023 11:56
Quiddity Leaderboard ASX Sep 23: Intra-Review Replacement for BKL and Many Other Expected Changes
Blackmores Ltd could be deleted from the ASX 200 index and Neuren Pharmaceuticals or Ventia could become the replacement. This could be announced...
Janaghan Jeyakumar, CFA
Follow
464 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x